Interferon beta treatment in multiple sclerosis: The European clinical trials

Multiple Sclerosis

Volumn 1, Issue 6, 1996, Pages 317-320

  Comi, G ^a   Martinelli, V ^a   Filippi, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Clinical trials; Interferon beta; MRI; Multiple sclerosis

Indexed keywords

BETA INTERFERON;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EUROPE; HUMAN; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CLINICAL TRIALS, PHASE II; DOUBLE-BLIND METHOD; EUROPE; HUMANS; INTERFERON-BETA; MULTICENTER STUDIES; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030178045     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859600100604     Document Type: Article

References (15)

1. Comi G et al. (1995) Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study. Multiple Sclerosis 1; (suppl 1): 24-27.
2. Fernandez O et al. (1995) Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter randomized clinical trial. Multiple Sclerosis 1; (suppl 1): 67-69.
3. Fieschi C. (1995) Human recombinant interferon beta in the treatment of relapsing-remitting multiple sclerosis. Neuroimmunol (suppl 1): 14 (abstract).
4. Filippi M et al. (1995a) Correlations between changes in disability and T2 - weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 45: 255-260.
5. Filippi M et al. (1995b) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118: 1601-1612.
6. Filippi M et al. (1995c) Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiat 58: 31-37.
7. Gass A et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36: 62-67.
8. Jacobs L. (1995) New perspectives in treatment of MS: results with recombinant Interferon beta-1a. J Neuroimmunol (suppl 1): 14 (abstract).
9. Paty DW, Li DK, UBC MS/MRI study group and the IFNB multiple sclerosis study group. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662-667.
10. Stone LA et al. (1995) The effects of interferon-β on blood-brain barrier disruption demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 37: 611-619.
11. The IFNB Multiple Sclerosis study group. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655-661.
12. The IFNB Multiple sclerosis study group and the university of British Columbia MS/MRI analysis group. (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45: 1277-1285.
13. Van Walderveen MAA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (T1 -weighted) spin-echo images. Neurology 45: 1684-1690.
14. Weinshenker BG et al. (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114: 1045-1050.
15. Weinshenker BG et al. (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112: 1419-1428.